Self-Selection Effects in Smokers Attending Lung Cancer Screening A 9.5-Year Population-Based Cohort Study in Varese, Italy

被引:16
作者
Dominioni, Lorenzo [1 ]
Rotolo, Nicola [1 ]
Poli, Albino [2 ]
Paolucci, Massimo [3 ]
Sessa, Fausto [4 ]
D'Ambrosio, Vincenzo [5 ]
Paddeu, Antonio [6 ]
Mantovani, William [2 ]
Imperatori, Andrea [1 ]
机构
[1] Univ Insubria, Ctr Thorac Surg, Dept Surg Sci, I-21100 Varese, Italy
[2] Univ Verona, Dept Med & Publ Hlth, I-37100 Verona, Italy
[3] Osped S Antonio Abate, Dept Radiol, Gallarate, Italy
[4] Univ Insubria, Dept Human Morphol, I-21100 Varese, Italy
[5] Osped S Antonio Abate, Thorac Med Unit, Dept Med, Gallarate, Italy
[6] Osped S Anna Como, Resp Care Unit, Dept Med, Como, Italy
关键词
Lung cancer screening; self-selection; population-based study; JAPAN; PROGRAM; PREFECTURE; MORTALITY; PROSTATE; VARESE; DEATH; RISK;
D O I
10.1097/JTO.0b013e3181d2efc7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: We hypothesize that mortality risk profile of participants and nonparticipants in nonrandomized lung cancer (LC) screening of smokers may be different. Methods: In 1997, a population-based cohort of 5815 smokers of Varese Province was invited to nonrandomized LC screening by annual chest x-ray examination for 4 years. LC risk factors and screening participation rate were recorded. Except for screening, the whole cohort received usual care. After 9.5-year observation, we compared mortality of participants versus nonparticipants by assessing age-standardized all-cause mortality rate ratio (MRR) and disease group-specific MRR with 95% confidence intervals (95% CI). Results: Self-selected screening participants were 21% of cohort. Participants were younger (p < 0.001), were more frequently current smokers (p = 0.019), had more pack-years of smoking (p < 0.0001), and had higher rate of LC family history (p < 0.0001) and of occupational LC risk (p < 0.0001) relative to nonparticipants. In logistic regression analysis familial LC, occupational risk and pack-years smoked were significant predictors of participation in screening and of developing LC. Participants displayed a healthy effect, as shown by all-cause MRR = 0.67 (95% CI, 0.53-0.84), all cancers except LC MRR = 0.61 (95% CI, 0.41-0.91), cardiovascular diseases MRR = 0.38 (95% CI, 0.22-0.63), and noncancer disease other than cardiovascular or respiratory MRR = 0.57 (95% CI, 0.34-0.92). The LC mortality (MRR = 1.40; 95% CI, 1.03-1.91) was higher in participants relative to nonparticipants (p = 0.031). Conclusion: The selection effect in LC screening participants was dual: healthy effect and higher LC mortality. In assessing the overall effectiveness of LC screening on a population level, a higher LC mortality risk in participants should be considered.
引用
收藏
页码:428 / 435
页数:8
相关论文
共 29 条
[1]  
[Anonymous], VAR CANC REG
[2]  
[Anonymous], 1976, Cancer incidence in five continents
[3]  
[Anonymous], EUROPEAN UNION PUBLI
[4]  
Azienda Sanitaria Locale della Provincia di Varese, VAR PROV EP OBS
[5]   A 9-year follow-up study of participants and nonparticipants in sigmoidoscopy screening:: Importance of self-selection [J].
Blom, Johannes ;
Yin, Li ;
Liden, Annika ;
Dolk, Anders ;
Jeppsson, Bengt ;
Pahlman, Lars ;
Holmberg, Lars ;
Nyren, Olof .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2008, 17 (05) :1163-1168
[6]   Toward understanding non participation in sigmoidoscopy screening for colorectal cancer [J].
Blom, Johannes ;
Yin, Li ;
Liden, Annika ;
Dolk, Anders ;
Jeppsson, Bengt ;
Pahlman, Lars ;
Holmberg, Lars ;
Nyren, Olof .
INTERNATIONAL JOURNAL OF CANCER, 2008, 122 (07) :1618-1623
[7]   Prostate cancer specific mortality in the Florence screening pilot study cohort 1992-1993 [J].
Ciatto, Stefano ;
Gervasi, Ginetta ;
Gorini, Giuseppe ;
Lombardi, Claudio ;
Zappa, Marco ;
Crocetti, Emanuele .
EUROPEAN JOURNAL OF CANCER, 2006, 42 (12) :1858-1862
[8]  
Dominioni L, 2000, CANCER-AM CANCER SOC, V89, P2345, DOI 10.1002/1097-0142(20001201)89:11+<2345::AID-CNCR5>3.0.CO
[9]  
2-B
[10]   Death certificates provide an adequate source of cause of death information when evaluating lung cancer mortality: An example from the Mayo Lung Project [J].
Doria-Rose, V. Paul ;
Marcus, Pamela M. .
LUNG CANCER, 2009, 63 (02) :295-300